1.36 USD
▲+0.05+2.26%
盘后 1.31 -1.50%
2026-08-03
市值
$70.58M
市盈率
—
EPS
-0.27
股息率
—
52 周区间
0.39 – 1.57
成交量
123.03K
Beta
0.70
目标价
3.17
52W 低 0.3952W 高 1.57
价格走势
公司简介
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company’s lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Feds...